Previous 10 | Next 10 |
home / stock / cvs / cvs articles
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practice will meet this week to consider and recommend wh...
MedImpact’s attempt to recoup approximately $200 million following its purchase of Rite Aid Corp’s (OTC:RADCQ) pharmacy benefits unit h...
Vice President Kamala Harris is reportedly forging ties with corporate leaders, extending an olive branch to a demographic increasingly leaning tow...
NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigati...
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these b...
AbbVie Inc’s (NYSE:ABBV) top-selling arthritis drug, Humira, has managed to retain over 80% of its patients even after facing nine lower-pric...
CVS Health Corporation (NYSE:PVH) shares closed slightly higher during Wednesday's session. On May 30, JPMorgan analyst Lisa Gill maintained C...
The mass retirement of the boomer generation has been anticipated as one of the most impactful economic events of the 21st century. Economists are ...
During times of turbulence and uncertainty in the markets, even when markets are at all-time highs, many investors turn to dividend-yielding stocks...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 15, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased securities of CVS Health Corporat...
CVS Health to hold second quarter 2024 earnings conference call PR Newswire WOONSOCKET, R.I. , July 8, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, August 7 th , 2024, at 8:00 a.m. ET ...
2024-07-03 08:15:00 ET Some beaten-down stocks have significant upside potential and, therefore, present attractive buying opportunities for investors. However, other companies that are failing to keep pace with the market and are likely to keep struggling for a long time aren't worth inves...